Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case

Thrombopoietin receptor agonists (TPO‐RAs) are used as effective alternative treatments in ITP patients unresponsive to first‐/second‐line therapies. TPO‐RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Cristina, Volpicelli, Paola, Baldacci, Erminia, Ferrara, Grazia, Di Rocco, Alice, Ferretti, Antonietta, Porrazzo, Marika, Mazzucconi, Maria Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538052/
https://www.ncbi.nlm.nih.gov/pubmed/28781864
http://dx.doi.org/10.1002/ccr3.920
_version_ 1783254293526085632
author Santoro, Cristina
Volpicelli, Paola
Baldacci, Erminia
Ferrara, Grazia
Di Rocco, Alice
Ferretti, Antonietta
Porrazzo, Marika
Mazzucconi, Maria Gabriella
author_facet Santoro, Cristina
Volpicelli, Paola
Baldacci, Erminia
Ferrara, Grazia
Di Rocco, Alice
Ferretti, Antonietta
Porrazzo, Marika
Mazzucconi, Maria Gabriella
author_sort Santoro, Cristina
collection PubMed
description Thrombopoietin receptor agonists (TPO‐RAs) are used as effective alternative treatments in ITP patients unresponsive to first‐/second‐line therapies. TPO‐RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO‐RAs can be suspended maintaining a sustained response.
format Online
Article
Text
id pubmed-5538052
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55380522017-08-04 Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case Santoro, Cristina Volpicelli, Paola Baldacci, Erminia Ferrara, Grazia Di Rocco, Alice Ferretti, Antonietta Porrazzo, Marika Mazzucconi, Maria Gabriella Clin Case Rep Case Reports Thrombopoietin receptor agonists (TPO‐RAs) are used as effective alternative treatments in ITP patients unresponsive to first‐/second‐line therapies. TPO‐RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO‐RAs can be suspended maintaining a sustained response. John Wiley and Sons Inc. 2017-07-13 /pmc/articles/PMC5538052/ /pubmed/28781864 http://dx.doi.org/10.1002/ccr3.920 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Santoro, Cristina
Volpicelli, Paola
Baldacci, Erminia
Ferrara, Grazia
Di Rocco, Alice
Ferretti, Antonietta
Porrazzo, Marika
Mazzucconi, Maria Gabriella
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title_full Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title_fullStr Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title_full_unstemmed Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title_short Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
title_sort repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538052/
https://www.ncbi.nlm.nih.gov/pubmed/28781864
http://dx.doi.org/10.1002/ccr3.920
work_keys_str_mv AT santorocristina repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT volpicellipaola repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT baldaccierminia repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT ferraragrazia repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT diroccoalice repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT ferrettiantonietta repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT porrazzomarika repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase
AT mazzucconimariagabriella repeatedsuccessfuluseofeltrombopaginchronicprimaryimmunethrombocytopeniadescriptionofanintriguingcase

Ejemplares similares